Exact Mass: 314.00157060000004
Exact Mass Matches: 314.00157060000004
Found 203 metabolites which its exact mass value is equals to given mass value 314.00157060000004
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
5'-Phosphoribosyl-N-formylglycinamide
C8H15N2O9P (314.05151500000005)
5-phosphoribosyl-n-formylglycinamide, also known as N-formyl-gar or N-formylglycinamide ribonucleotide, is a member of the class of compounds known as glycinamide ribonucleotides. Glycinamide ribonucleotides are compounds in which the amide N atom of glycineamide is linked to the C-1 of a ribosyl (or deoxyribosyl) moiety. Nucleotides have a phosphate group linked to the C5 carbon of the ribose (or deoxyribose) moiety. 5-phosphoribosyl-n-formylglycinamide is slightly soluble (in water) and a moderately acidic compound (based on its pKa). 5-phosphoribosyl-n-formylglycinamide can be found in a number of food items such as rosemary, mexican groundcherry, common wheat, and bitter gourd, which makes 5-phosphoribosyl-n-formylglycinamide a potential biomarker for the consumption of these food products. 5-phosphoribosyl-n-formylglycinamide exists in all living species, ranging from bacteria to humans. In humans, 5-phosphoribosyl-n-formylglycinamide is involved in few metabolic pathways, which include azathioprine action pathway, mercaptopurine action pathway, purine metabolism, and thioguanine action pathway. 5-phosphoribosyl-n-formylglycinamide is also involved in several metabolic disorders, some of which include mitochondrial DNA depletion syndrome, aICA-Ribosiduria, molybdenum cofactor deficiency, and xanthinuria type I. 5-Phosphoribosyl-N-formylglycinamide, also known as FGAR or N-formyl-GAR, belongs to the class of organic compounds known as glycinamide ribonucleotides. Glycinamide ribonucleotides are compounds in which the amide N atom of glycineamide is linked to the C-1 of a ribosyl (or deoxyribosyl) moiety. FGAR is an extremely weak basic (essentially neutral) compound (based on its pKa). FGAR is a substrate for phosphoribosylformylglycinamidine synthase. It is involved in aminoimidazole ribonucleotide biosynthesis and plays a vital role in purine metabolism as well as in the conversion of glutamine to glutamate.
Clorazepate
C16H11ClN2O3 (314.04581659999997)
Clorazepate is only found in individuals that have used or taken this drug. It is a water-soluble benzodiazepine derivative effective in the treatment of anxiety. It has also muscle relaxant and anticonvulsant actions. [PubChem]Benzodiazepines bind nonspecifically to benzodiazepine receptors BNZ1, which mediates sleep, and BNZ2, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell. D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
Wedelolactone
Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibits the IKK Complex. Wedelolactone also inhibits 5-lipoxygenase (5-Lox) with an IC50 of 2.5 μM. Wedelolactone induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt. Wedelolactone can extract from Eclipta alba, and it can be used for the research of cancer[1][2][3]. Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibits the IKK Complex. Wedelolactone also inhibits 5-lipoxygenase (5-Lox) with an IC50 of 2.5 μM. Wedelolactone induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt. Wedelolactone can extract from Eclipta alba, and it can be used for the research of cancer[1][2][3]. Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibits the IKK Complex. Wedelolactone also inhibits 5-lipoxygenase (5-Lox) with an IC50 of 2.5 μM. Wedelolactone induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt. Wedelolactone can extract from Eclipta alba, and it can be used for the research of cancer[1][2][3].
Calcium salicylate
D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates
Laccaic acid D
Laccaic acid D is found in green vegetables. Laccaic acid D is a constituent of rhubarb rhizomes
Triclocarban
C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D004785 - Environmental Pollutants > D014873 - Water Pollutants D000890 - Anti-Infective Agents
Glycerylphosphorylinositol
Iodoantipyrine
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
2'-hydroxypseudobaptigenin
2-hydroxypseudobaptigenin is a member of the class of compounds known as isoflavones. Isoflavones are polycyclic compounds containing a 2-isoflavene skeleton which bears a ketone group at the C4 carbon atom. 2-hydroxypseudobaptigenin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 2-hydroxypseudobaptigenin can be found in a number of food items such as sorghum, cucurbita (gourd), rubus (blackberry, raspberry), and pineapple, which makes 2-hydroxypseudobaptigenin a potential biomarker for the consumption of these food products.
Wedelolactone
Wedelolactone is a member of the class of coumestans that is coumestan with hydroxy substituents as positions 1, 8 and 9 and a methoxy substituent at position 3. It has a role as an antineoplastic agent, an EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor, an apoptosis inducer, a hepatoprotective agent and a metabolite. It is a member of coumestans, a delta-lactone, an aromatic ether and a polyphenol. It is functionally related to a coumestan. Wedelolactone is a natural product found in Sphagneticola calendulacea, Eclipta alba, and other organisms with data available. A member of the class of coumestans that is coumestan with hydroxy substituents as positions 1, 8 and 9 and a methoxy substituent at position 3. Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibits the IKK Complex. Wedelolactone also inhibits 5-lipoxygenase (5-Lox) with an IC50 of 2.5 μM. Wedelolactone induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt. Wedelolactone can extract from Eclipta alba, and it can be used for the research of cancer[1][2][3]. Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibits the IKK Complex. Wedelolactone also inhibits 5-lipoxygenase (5-Lox) with an IC50 of 2.5 μM. Wedelolactone induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt. Wedelolactone can extract from Eclipta alba, and it can be used for the research of cancer[1][2][3]. Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibits the IKK Complex. Wedelolactone also inhibits 5-lipoxygenase (5-Lox) with an IC50 of 2.5 μM. Wedelolactone induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt. Wedelolactone can extract from Eclipta alba, and it can be used for the research of cancer[1][2][3].
1,9-Dihydroxy-4-(methylsulfinyl)-6H-indolo[3,2,1-de][1,5]naphthyridine-6-one
1,3,6-trihydroxy-2-methoxymethyl-9,10-anthraquinone
2,3,8,10-Tetrahydroxy[2]benzopyrano[4,3-b][1]benzopyran-7(5H)-one
Triclocarban
C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D004785 - Environmental Pollutants > D014873 - Water Pollutants D000890 - Anti-Infective Agents CONFIDENCE standard compound; INTERNAL_ID 2417 CONFIDENCE standard compound; INTERNAL_ID 8807 CONFIDENCE standard compound; INTERNAL_ID 8245 CONFIDENCE standard compound; INTERNAL_ID 4187 INTERNAL_ID 4187; CONFIDENCE standard compound CONFIDENCE standard compound; EAWAG_UCHEM_ID 2988
Perfluorohexanoic acid
CONFIDENCE standard compound; INTERNAL_ID 5946 CONFIDENCE standard compound; INTERNAL_ID 2406 INTERNAL_ID 2406; CONFIDENCE standard compound CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 8771 CONFIDENCE standard compound; EAWAG_UCHEM_ID 2715
4-{5-[(4-nitrobenzyl)sulfanyl]-1,3,4-oxadiazol-2-yl}pyridine
C14H10N4O3S (314.04735900000003)
6-Bromo-3-methylflavone
C16H11BrO2 (313.99423659999997)
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.410
1,3,8-Trihydroxy-9-methoxy-11H-benzofuro[2,3-b][1]benzopyran-11-one
11H-Benzofuro(2,3-b)(1)benzopyran-11-one, 1, 3,8-trihydroxy-2-methoxy-
ophioglonin
A homoflavonoid that is isochromeno[4,3-b]chromen-7(5H)-one substituted by hydroxy groups at positions 3, 4, 8 and 10. Isolated from Ophioglossum petiolatum, it exhibits anti-HBV activity.
Endocrocin
A trihydroxyanthraquinone that is 9,10-anthraquinone which is substituted by a carboxy group at position 2, a methyl group at position 3, and hydroxy groups at positions 1, 6, and 8.
8-(methoxycarbonyl)-1-hydroxy-9-oxo-9h-xanthene-3-carboxylic acid
1,3,7-Trihydroxy-8-methoxy-(1)benzofuro(2,3-b)chromen-11-one
2-Methoxy-1,3,7-trihydroxy-11H-benzofuro[2,3-b][1]benzopyran-11-one
1,6,8-trihydroxy-3-methyl-9,10-dioxoanthracene-2-carboxylic acid
Laccaic acid D
A trihydroxyanthraquinone that is that is 3,6,8-trihydroxy-9,10-anthraquinone substituted by methyl and carboxy groups at positions 1 and 2 respectively. A minor component of LAC dye together with laccaic acids A, B and C.
5-CHLORO-2-(4-CHLORO-2-NITRO-PHENYLSULFANYL)-PHENYLAMINE
5-Benzyl-3-(4-bromophenyl)-1,2,4-oxadiazole
C15H11BrN2O (314.00546959999997)
4-AMINO-2-ISOPROPYLTHIO-5-(PHENYLSULFONYL)THIAZOLE
3-bromo-4-(oxan-4-ylmethoxy)benzoic acid
C13H15BrO4 (314.01536500000003)
10-Bromo-5H-dibenzo[b,f]azepine-5-carboxamide
C15H11BrN2O (314.00546959999997)
2-(4-BROMOPHENYL)-PROPANEDIOIC ACID, 1,3-DIETHYL ESTER
C13H15BrO4 (314.01536500000003)
6-BROMO-2-PHENYLIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE
C15H11BrN2O (314.00546959999997)
phenylmercury chloride
D010575 - Pesticides > D005659 - Fungicides, Industrial > D010663 - Phenylmercury Compounds
2-BROMO-5-(1-METHYL-2-(PYRIDIN-2-YL)-1H-IMIDAZOL-4-YL)PYRIDINE
[3-(bromomethyl)-1-benzofuran-2-yl]-phenylmethanone
C16H11BrO2 (313.99423659999997)
3,4-DIAMINO-THIENO[2,3-B]THIOPHENE-2,5-DICARBOXYLIC ACID DIETHYL ESTER
ethyl 4-chlorosulfonyl-1-hydroxynaphthalene-2-carboxylate
C13H11ClO5S (314.00157060000004)
5-Benzyl-3-(2-bromophenyl)-1,2,4-oxadiazole
C15H11BrN2O (314.00546959999997)
(4-Pyridyl)acetone Hydrochloride
C12H12BrFN2O2 (314.00661239999994)
Tesicam
C16H11ClN2O3 (314.04581659999997)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
2-Bromomethyl-4-fluorophenylboronic acid pinacol ester
2-Methyl-2-propanyl 6-bromo-4-fluoro-1H-indazole-1-carboxylate
C12H12BrFN2O2 (314.00661239999994)
(4-BROMO-2,6-DIFLUOROPHENYL)-1,1,2,3,3,3-HEXAFLUOROPROPYLETHER
C13H15BrO4 (314.01536500000003)
ethyl 2-[3,5-bis(trifluoromethyl)phenyl]-2-oxoacetate
C12H8F6O3 (314.03776099999993)
2-(2-(2,2,2-Trifluoroethoxy)phenoxy)ethyl methanesulfonate
C11H13F3O5S (314.04357640000006)
methyl (2R)-4-hydroxy-1-methylpyrrolidine-2-carboxylate
C15H11BrN2O (314.00546959999997)
3-(3-chloro-4-(chlorodifluoromethyl)thiophenyl)-1,1-dimethylurea
C10H10Cl2F2N2OS (313.98589340000007)
3-(4-BROMOPHENYL)-2-METHYLQUINAZOLIN-4(3H)-ONE
C15H11BrN2O (314.00546959999997)
2-[2-[(4,5-DICHLORO-1H-IMIDAZOL-1-YL)METHYL]PHENOXY]ETHANOHYDRAZIDE
(5-chloro-2-methoxyphenyl)-(3,5-dichlorophenyl)methanone
ISOPROPYL 3-CHLORO-5-METHOXY-6-METHYLBENZO[B]THIOPHENE-2-CARBOXYLATE 1-OXIDE
1-PHENYL-1H-5-(5-BROMO-2-HYDROXYPHENYL)PYRAZOLE
C15H11BrN2O (314.00546959999997)
Benzyl (2,6-dichloro-5-fluoropyridin-3-yl)carbamate
C13H9Cl2FN2O2 (314.00250859999994)
2-(4-(Bromomethyl)-3-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
2-(4-(Bromomethyl)-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
1-BENZENESULFONYL-4-BROMO-3,5-DIMETHYL-1H-PYRAZOLE
methyl (2Z,4Z)-2-(bromomethyl)-5-chloro-5-phenylpenta-2,4-dienoate
6-chloro-3-(4-chlorophenyl)-[1,2,4]triazolo[3,4-a]phthalazine
(2-BROMO-4-FORMYL-PHENOXY)-ACETIC ACID TERT-BUTYL ESTER
C13H15BrO4 (314.01536500000003)
4-AMINO-N-(6-CHLORO-5-METHOXY-4-PYRIMIDINYL)BENZENESULFONAMIDE
C11H11ClN4O3S (314.02403660000004)
tert-Butyl 3-bromo-5-fluoro-1H-indazole-1-carboxylate
C12H12BrFN2O2 (314.00661239999994)
5-(4-BROMOPHENYL)-2,4-DIHYDRO-2-PHENYL-3H-PYRAZOL-3-ONE
C15H11BrN2O (314.00546959999997)
METHYL 4-HYDROXY-6-OXO-1-(3-(TRIFLUOROMETHYL)PHENYL)-1,6-DIHYDROPYRIDAZINE-3-CARBOXYLATE
2-(2-chloro-4-fluorophenyl)-6-(trifluoromethyl)pyrazolo[1,5-a]pyridine
(6R-trans)-7-AMino-8-oxo-3-[(1H-tetrazol-5-ylthio)Methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
C9H10N6O3S2 (314.02557900000005)
1-((2-BROMOPHENYL)SULFONYL)-3,5-DIMETHYL-1H-PYRAZOLE
N-Cbz-2-(hydroxyMethyl)homoMorpholine
C13H12BrFO3 (313.99537939999993)
3-(4-Bromophenyl)-5-(1-chloro-2-methylpropan-2-yl)-1,2,4-oxadiazole
2-(3-(BROMOMETHYL)-2-FLUOROPHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE
2-(5-(BROMOMETHYL)-2-FLUOROPHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE
TERT-BUTYL4-(2-IODOETHOXY)BUTANOATE
C10H19IO3 (314.03788940000004)
3-oxo-2-(2-oxo-2-thiophen-2-ylethylidene)-1,4-dihydroquinoxaline-6-carboxylic acid
3-(4-BROMOPHENYL)-5-(P-TOLYL)-1,2,4-OXADIAZOLE
C15H11BrN2O (314.00546959999997)
N-(5-Bromo-2-methylphenyl)-3-cyanobenzamide
C15H11BrN2O (314.00546959999997)
1-(3-Bromo-4-fluorophenyl)-4-oxocyclohexanecarboxylic acid
C13H12BrFO3 (313.99537939999993)
1,1-difluoroethene,1,1,2,3,3,3-hexafluoroprop-1-ene,1,1,2,2-tetrafluoroethene
(Z)-5-((1-(4-nitrophenyl)-1H-pyrrol-2-yl)methylene)-2-thioxoimidazolidin-4-one
C14H10N4O3S (314.04735900000003)
1-benzyl-4-chloro-3-nitroquinolin-2(1H)-one
C16H11ClN2O3 (314.04581659999997)
1-(2-Furanyl)-3-(phenylthio)-3-thiophen-2-yl-1-propanone
C17H14O2S2 (314.04351840000004)
3-chloro-N-(4,5-dihydro-1,3-thiazol-2-yl)-6-fluoro-1-benzothiophene-2-carboxamide
2,2,3,4,4,5,5,5-Octafluoro-3-(trifluoromethyl)pentanoic acid
7-[(3-Chlorobenzyl)oxy]-2-Oxo-2h-Chromene-4-Carbaldehyde
4-(5-{(Z)-[(2E)-2-imino-4-oxo-1,3-thiazolidin-5-ylidene]methyl}furan-2-yl)benzoic acid
(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(4-nitrophenoxy)oxane-2-carboxylate
C12H12NO9- (314.05120420000003)
5,7-Dihydroxy-3-(6-hydroxy-1,3-benzodioxol-5-yl)chromen-4-one
1-(1,2,3,4,5,6-Hexahydroxy-7-oxo-7lambda5-phosphabicyclo[4.1.0]heptan-7-yl)-2,3-dihydroxypropan-1-one
N(2)-Formyl-N(1)-(5-phospho-D-ribosyl)glycinamide
C8H15N2O9P (314.05151500000005)
A glycinamide ribonucleotide having a phosphate group at the 5-position and a formyl group on the glycine nitrogen.
5-chloropyridin-3-yl 1-acetyl-1H-indole-5-carboxylate
C16H11ClN2O3 (314.04581659999997)
2-(4-Bromophenyl)-5-(2-methylphenyl)-1,3,4-oxadiazole
C15H11BrN2O (314.00546959999997)
4-chloro-N-(4-chlorobenzyl)-5-nitro-1H-pyrazole-3-carboxamide
C11H8Cl2N4O3 (313.99734379999995)
N-(2-chlorophenyl)-5-(2-pyridinyl)-2-thiophenecarboxamide
2-Amino-4-(2-chlorophenyl)-6-(ethylthio)pyridine-3,5-dicarbonitrile
N-[(3-chloro-4-fluoroanilino)-oxomethyl]-4-methyl-5-thiadiazolecarboxamide
5-chloropyridin-3-yl 1-acetyl-1H-indole-4-carboxylate
C16H11ClN2O3 (314.04581659999997)
3-(1,3-Benzodioxol-5-yl)-5-(2-furanylmethylidene)-2-imino-4-thiazolidinone
4-[(5H-[1,2,4]triazino[5,6-b]indol-3-ylthio)methyl]-2-thiazolamine
[2-Hydroxy-1-(1-oxoisochromen-3-yl)butyl] hydrogen sulate
C13H14O7S (314.04602140000003)
Clorazepic acid
C16H11ClN2O3 (314.04581659999997)
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
4,5-dihydroxy-7-methoxy-9,10-dioxoanthracene-2-carboxylic acid
8,13-dihydroxy-4-[(s)-methanesulfinyl]-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-3,5,7,9(16),10(15),11,13-heptaen-2-one
5,18-dihydroxy-7-methyl-2,10,15-trioxatetracyclo[9.7.0.0³,⁸.0¹³,¹⁷]octadeca-1(18),3(8),4,6,11,13(17)-hexaene-9,16-dione
20-methoxy-5,7,12,16,18-pentaoxapentacyclo[11.7.0.0³,¹¹.0⁴,⁸.0¹⁵,¹⁹]icosa-1(20),3,8,10,13,15(19)-hexaen-2-one
8-hydroxy-4-methanesulfinyl-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-3,5(16),7,9,11,14-hexaene-2,13-dione
1,5,8-trihydroxy-3-methyl-9,10-dioxoanthracene-2-carboxylic acid
(10r)-3,7,8,10-tetrahydroxy-10h-5,11-dioxatetraphen-12-one
8-hydroxy-4-[(s)-methanesulfinyl]-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-3,5(16),7,9,11,14-hexaene-2,13-dione
2-acetyl-1,3,6,8-tetrahydroxyanthracene-9,10-dione
5,7,13-trihydroxy-14-methoxy-2,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1(10),3,5,7,11(16),12,14-heptaen-9-one
1,3,5-trihydroxy-6-methoxy-9,10-dioxoanthracene-2-carbaldehyde
1,3,7,8-tetrahydroxy-10h-5,11-dioxatetraphen-12-one
1,3,6,9-tetrahydroxy-10h-5,11-dioxatetraphen-12-one
8,13-dihydroxy-4-methanesulfinyl-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-3,5,7,9(16),10(15),11,13-heptaen-2-one
4,7-dihydroxy-5-methoxy-9,10-dioxoanthracene-2-carboxylic acid
1-acetyl-2,4,5,7-tetrahydroxyanthracene-9,10-dione
(10s)-3,7,8,10-tetrahydroxy-10h-5,11-dioxatetraphen-12-one
2-(4-bromophenyl)-2-oxoethyl (2r,3r)-3-hydroxy-2-methylbutanoate
C13H15BrO4 (314.01536500000003)
3,5,13-trihydroxy-14-methoxy-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-9-one
5,7,15-trihydroxy-6-methoxy-2,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1(10),3,5,7,11(16),12,14-heptaen-9-one
5,7,15-trihydroxy-14-methoxy-2,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1(10),3,5,7,11(16),12,14-heptaen-9-one
5,7,14-trihydroxy-13-methoxy-2,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1(10),3,5,7,11(16),12,14-heptaen-9-one
5,7,14-trihydroxy-6-methoxy-2,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1(10),3,5,7,11(16),12,14-heptaen-9-one
7-(2,3-dihydroxyphenyl)-9-hydroxy-2h-[1,3]dioxolo[4,5-g]chromen-8-one
2-(4-bromophenyl)-2-oxoethyl 3-hydroxy-2-methylbutanoate
C13H15BrO4 (314.01536500000003)